Trial Search Results

Group Therapy for Primary Breast Cancer

The purpose of this study is to determine whether women with primary breast cancer who were randomly assigned to receive a brief group therapy would show a greater reduction in mood disturbance over time compared to those randomized to the control condition. We also hypothesized that women who were highly distressed at baseline would show the greatest benefit from participating in a support group, and that therapists with more training and experience would be most effective in reducing distress.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):


  • Behavioral: Brief supportive-expressive group therapy


Phase 3


Inclusion Criteria:

   - : 1) diagnosis of primary, biopsy-proven breast cancer, stages I through IIIA; 2)
   diagnosis occurred no more than 12 months prior to recruitment; 3) completion of
   initial surgical treatment; and 4) no detectable disease present.

Exclusion Criteria:

   - 1) evidence of metastases beyond adjacent lymph nodes, including chest wall
   involvement, bone or viscera; 2) recurrence of the cancer prior to randomization; 3)
   diagnosis of other cancers (except for basal cell or squamous cell carcinoma of the
   skin or in situ cervical cancer) within the past 10 years; 4) any other major medical
   problems likely to limit life expectancy to less than 10 years; 5) a history of major
   psychiatric illness for which the patient was hospitalized or medicated, except for a
   diagnosis of depression or anxiety treated for a period of less than one year; and 6)
   attendance at a cancer support group for more than two months.

Ages Eligible for Study

0 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting